NEJM Knowledge+ is a product of NEJM Group — a division of the Massachusetts Medical Society — the organization behind the New England Journal of Medicine, NEJM Journal Watch, NEJM Catalyst, NEJM Evidence, NEJM Healer, and NEJM Resident 360. Health care professionals around the world rely on these products for context on the latest research advances and information that enriches everyday clinical decisions.
The same exacting standards have guided the development of NEJM Knowledge+. More than 300 authors and editors — all practicing physicians — work to ensure questions are accurate, credible, relevant, and current. These are learning materials you can trust.
Our products — NEJM Knowledge+ Internal Medicine Board Review, NEJM Knowledge+ Family Medicine Board Review, NEJM Knowledge+ Pediatrics Board Review, NEJM Knowledge+ PA Board Review — serve busy physicians, residents, and PAs. It’s designed to help clinicians develop and deepen their knowledge and improve insight into their own learning.
NEJM Knowledge+ Pain Management and Opioids was developed to help practicing clinicians earn DEA and state-mandated CME and give them the confidence that they are following guidelines when treating their patients with pain.
NEJM Group partnered with Area9 Lyceum — a physician-led pioneer in adaptive learning — to create a first-of-its-kind product in continuous medical education. By customizing every aspect of the experience to the learner’s particular needs, the adaptive learning platform makes lifelong learning and board review more efficient and improves proficiency.
NEJM Knowledge+ content is created and maintained through a unique and rigorous process that relies on leading educators, subspecialty experts, training programs, experienced editors, and our users. For more on the process watch this video on our blog. See our list of contributors, led by Dr. Ole-Petter Hamnvik.